Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-14

Clinical Trial Update: Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM) [NA]

View source ↗

Summary

An ongoing Yale University clinical trial is investigating whether reversibility of brain glucose transport can be achieved in individuals with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Diabetes Mellitus, Type 2 | NA | Status: RECRUITING